Canbi  Pharma  Tech  Cyfyngedig
1375108-46-5 7- (4,4,5, 5- tetramethyl -1, 3, 2- dioxaborolan -2- yl) quinazoline

1375108-46-5 7- (4,4,5, 5- tetramethyl -1, 3, 2- dioxaborolan -2- yl) quinazoline

Cas: 1375108-46-5
MF: C14H17BN2O2
MW: 256.11
Einecs:
Mdl no .: mfcd18205965

Anfon ymchwiliad
Disgrifiad

Eiddo
Berwi: 390.5 ± 15.0 gradd
Dwysedd 1.14 ± 0.1 g/cm3
Temp Storio . o dan nwy anadweithiol (nitrogen neu argon) ar 2-8 gradd

 

Cais:

Fel canolradd a ligand mewn synthesis organig, gall gymryd rhan mewn amrywiol ymatebion, megis adweithiau cyplu suzuki .

 

Cyfystyron:

1375108-46-5

7- (4,4,5, 5- tetramethyl -1, 3, 2- dioxaborolan -2- yl) quinazoline

Quinazoline, 7- (4,4,5, 5- tetramethyl -1, 3, 2- dioxaborolan -2- yl)-

7- (tetramethyl -1, 3, 2- dioxaborolan -2- yl) quinazoline

 

 

Tagiau poblogaidd: 1375108-46-5 7- (4,4,5, 5- tetramethyl -1, 3, 2- dioxaborolan -2- yl) quinazoline, China 1375108-46-5 7- (4,4,5, 5- tetramethyl -1, 3, 2- Dioxaborolan -2- yl) gweithgynhyrchwyr quinazoline, cyflenwyr

Inquiry
goTop

(0/10)

clearall